For those still inclined to Trust The ScienceTM
… found no significant difference between the number of deaths in the vaccinated versus placebo arms for the first 20 weeks of the trial, the placebo-controlled portion of the trial. After Week 20, as subjects in the Placebo were unblinded and vaccinated, deaths among this still unvaccinated cohort of this group slowed and eventually plateaued. Deaths in the BNT162b2 vaccinated subjects continued at the same rate. Our analysis revealed inconsistencies between the subject data listed in the 6-Month Interim Report and publications authored by Pfizer/BioNTech trial site administrators. Most importantly, we found evidence of an over 3.7-fold increase in number of deaths due to cardiovascular events in BNT162b2 vaccinated subjects compared to Placebo controls. This significant adverse event signal was not reported by Pfizer/BioNTech…
Of the 38 deaths reported in the 6-Month Interim Report… 14 subjects died from a cardiovascular event, over one-third of all deaths (36.8%). Of these 14, 11 were from the BNT162b2 vaccinated trial arm and 3 from the Placebo only trial arm. This represents a 3.7-fold increase in cardiovascular events in subjects who received the BNT162b2 vaccine. Thomas et al. [7] and Pfizer/BioNTech’s Summary Clinical Safety [11] do not identify or remark on this clear serious adverse event signal…
Michels, C.; Perrier, D.; Kunadhasan, J.; Clark, E.; Gehrett, J.; Gehrett, B.; Kwiatek, K.; Adams, S.; Chandler, R.; Stagno, L.; Damian, T.; Delph, E.; Flowers, C. Forensic Analysis of the 38 Subject Deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial. Preprints 2023, 2023090131. https://doi.org/10.20944/preprints202309.0131.v1
Oh, and once the trial was unblinded, one participant had a Moderna injection after Pfizer Doses 1 and 2. His death a few weeks later was reported as an unvaccinated Placebo Death!
Subject # 10841470 is an obese 65-year-old Hispanic male with a medical history including pulmonary fibrosis and hypertension. He was in the Placebo arm of the trial and received Doses 1 and 2 on September 30 and October 21, 2020, respectively. On December 23, 2020, the subject received Dose 1 of the Moderna mRNA vaccine. This Protocol Deviation was reported in his CRF after the subject reported symptoms of COVID-19 on December 28, 2020 and was admitted to the hospital on December 31, 2020. While hospitalized, he became hypoxic and was intubated on January 2, 2021. He received monoclonal antibodies as part of his treatment in the hospital. Despite these efforts, the subject continued to deteriorate, lapsed into multisystem organ failure, and ultimately died on January 11, 2021. Subject #10841470 was in the List of Discontinued Subjects [10] as a “Death” and in
Page 8 of Michels, C.; Perrier, D.; Kunadhasan, J.; Clark, E.; Gehrett, J.; Gehrett, B.; Kwiatek, K.; Adams, S.; Chandler, R.; Stagno, L.; Damian, T.; Delph, E.; Flowers, C. Forensic Analysis of the 38 Subject Deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial. Preprints 2023, 2023090131. https://doi.org/10.20944/preprints202309.0131.v1
the 6-Month Interim Report [8] as a Placebo death with COVID-19 as the secondary cause of death. This is a misrepresentation of the subject’s clinical information. The subject should have been
discontinued from the Pfizer/BioNTech clinical trial because the “subject received non-study COVID19 vaccine”
Thanks to 100PercentFedUp for highlighting.